506687 — Transpek Industry Balance Sheet
0.000.00%
- IN₹6.62bn
- IN₹6.29bn
- IN₹6.50bn
- 98
- 72
- 40
- 84
Annual balance sheet for Transpek Industry, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 156 | 17.2 | 56.5 | 84.1 | 979 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 792 | 1,013 | 1,194 | 1,098 | 1,199 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,537 | 2,441 | 2,344 | 2,136 | 3,011 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,010 | 3,106 | 3,894 | 4,034 | 3,649 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,992 | 7,641 | 8,869 | 9,657 | 10,005 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,064 | 1,658 | 1,356 | 1,125 | 1,218 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,194 | 2,798 | 3,002 | 2,923 | 2,552 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 3,798 | 4,843 | 5,866 | 6,734 | 7,453 |
| Total Liabilities & Shareholders' Equity | 5,992 | 7,641 | 8,869 | 9,657 | 10,005 |
| Total Common Shares Outstanding |